Literature DB >> 1412763

Progressive albuminuria and glomerulosclerosis in a rat model of chronic renal allograft rejection.

J R Diamond1, N L Tilney, J Frye, G Ding, J McElroy, I Pesek-Diamond, H Yang.   

Abstract

A significant proportion of renal allografts fail within several months or years after transplantation, primarily because of chronic rejection. The etiology and pathophysiology of this condition remain unclear. We studied the renal function, morphology, and immunohistology, in parallel, among F344-to-Lewis allografts (n = 23) and isografts (n = 13) over the course of 24 weeks. Only an initial 10-day course of CsA (5 mg/kg/day) was given to both groups to prevent acute rejection. Hypertension did not develop, although awake systolic blood pressure was significantly higher in allografts at the end of the study. Significant differences in urine albumin excretion (UalbV) between isografts and allografts were evident as early as 4 weeks after engraftment but rose dramatically by 20 weeks (3.3 +/- 0.7 vs. 21.2 +/- 3.7 mg/day, respectively, P < .001). This pattern continued until the conclusion of the study (5.0 +/- 1.1 vs. 53.5 +/- 7.6 mg/day, P < .001). Serum creatinine values were only significantly elevated in allografts at 16 weeks, which temporally corresponded to the dramatic increase in UalbV. However, renal blood flow and glomerular filtration rate, measured by paraaminohippurate and inulin clearances, respectively, were significantly lower in allografted organs, at 24 weeks. The frequency of glomerulosclerosis lesions was significantly increased in allografted kidneys at 24 weeks and correlated with UalbV values. Glomerular localization of mononuclear leukocyte subsets were equivalent between allografts and isografts; however, the numbers of interstitial macrophages, CD8+, and pan-T-cells were all significantly greater in allografts at 24 weeks. The infiltration of significantly greater numbers of macrophages and lymphocytes into the tubulointerstitium of the allograft group suggests a mononuclear leukocyte effector cell mediation of the progressive glomerular abnormalities in this model of chronic renal allograft rejection in the rat.

Entities:  

Mesh:

Year:  1992        PMID: 1412763     DOI: 10.1097/00007890-199210000-00028

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  13 in total

1.  Establishment of a murine model of chronic corneal allograft dysfunction.

Authors:  Hua Gao; Weiyun Shi; Huaqing Gong; Yiqiang Wang; Ye Wang; Lixin Xie
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-05-16       Impact factor: 3.117

2.  Tofacitinib Halts Progression of Graft Dysfunction in a Rat Model of Mixed Cellular and Humoral Rejection.

Authors:  Jordi Rovira; María José Ramírez-Bajo; Elisenda Banon-Maneus; Marta Lazo-Rodríguez; Daniel Moya-Rull; Natalia Hierro-Garcia; Valeria Tubita; Gastón J Piñeiro; Ignacio Revuelta; Pedro Ventura-Aguiar; David Cucchiari; Federico Oppenheimer; Mercè Brunet; Josep M Campistol; Fritz Diekmann
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

3.  Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection.

Authors:  A Chandraker; H Azuma; K Nadeau; C B Carpenter; N L Tilney; W W Hancock; M H Sayegh
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

4.  Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection.

Authors:  H Azuma; A Chandraker; K Nadeau; W W Hancock; C B Carpenter; N L Tilney; M H Sayegh
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

5.  Impact of cyclosporin on the incidence and prevalence of chronic rejection in renal transplants.

Authors:  I J Beckingham; J S O'Rourke; S R Stubington; M Hinwood; M C Bishop; K M Rigg
Journal:  Ann R Coll Surg Engl       Date:  1997-03       Impact factor: 1.891

6.  13-cis retinoic acid inhibits development and progression of chronic allograft nephropathy.

Authors:  Judith Adams; Eva Kiss; Ana B V Arroyo; Mahnaz Bonrouhi; Qiang Sun; Zhen Li; Norbert Gretz; Anna Schnitger; Christos C Zouboulis; Manfred Wiesel; Jürgen Wagner; Peter J Nelson; Hermann-Josef Gröne
Journal:  Am J Pathol       Date:  2005-07       Impact factor: 4.307

7.  Mesenchymal stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft model.

Authors:  Marcella Franquesa; Esther Herrero; Joan Torras; Elia Ripoll; Maria Flaquer; Montse Gomà; Nuria Lloberas; Ignacio Anegon; Josep M Cruzado; Josep M Grinyó; Immaculada Herrero-Fresneda
Journal:  Stem Cells Dev       Date:  2012-05-18       Impact factor: 3.272

8.  Nephron supply is a major determinant of long-term renal allograft outcome in rats.

Authors:  H S Mackenzie; S G Tullius; U W Heemann; H Azuma; H G Rennke; B M Brenner; N L Tilney
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

9.  Long-term kidney isografts develop functional and morphologic changes that mimic those of chronic allograft rejection.

Authors:  S G Tullius; U Heemann; W W Hancock; H Azuma; N L Tilney
Journal:  Ann Surg       Date:  1994-10       Impact factor: 12.969

10.  Do alloreactivity and prolonged cold ischemia cause different elementary lesions in chronic allograft nephropathy?

Authors:  Immaculada Herrero-Fresneda; Joan Torras; Josep M Cruzado; Enric Condom; August Vidal; Marta Riera; Nuria Lloberas; Jeroni Alsina; Josep M Grinyo
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.